Impact of the CHA2DS2-VASc score on anticoag- ulation recommendations for atrial fibrillation. Am J Med 2012; 125: 603 - 606.Mason PK, Lake DE, DiMarco JP, Ferguson JD, Mangrum JM, Bilchick K, Moorman LP, Moorman JR. Impact of the CHA2DS2-VASc score on anticoag- ulation ...
The mean CHADS-VASc score was 3 ± 1.1 in those with LAA thrombus compared with 4 ± 1.4 in those without LAA thrombus (p = 0.14). The incidence of LAA thrombus did not demonstrate a proportional increase in relation to CHADS-VASc score (percentage of thrombus in CHADS-VASc scores of 1...
(HAS-BLED ≥3)Moderate (CHA2DS2-VASC = 1 in males) Stable CAD Up to 12th month: OAC and clopidogrel 75 mg/day Lifelong: OAC High (CHA2DS2-VASC ≥2)Stable CAD 4 weeks: triple therapy of OAC + aspirin 75-100 mg/day + clopidogrel 75 mg/day Up to 12th month: OAC and clopidogrel...
Objective To perform a systematic review and meta-analysis of the predictive abilities of CHADS2 and CHA2DS2-VASc in stroke and thromboembolism risk stratification of atrial fibrillation (AF) patients. Methods We searched PubMed and EMBASE for Eng-lish-language literature on comparisons of the diagn...
The CHADS2 score is used to identify AF patients at low risk of stroke and thus unlikely to benefit from oral anticoagulation (OAC), but does not adequately discriminate stroke risk in those with a score of 0-1. The CHA2DS2-VASc score improves stroke risk prediction in the overall AF pop...
CHA^sub 2^ds^sub 2^-VASc Score Tops CHADS^sub 2^ as Better Thromboembolism DeterminantANTICOAGULATION THERAPIESCHA^sub 2^ds^sub 2^-VASc Score Tops CHADS^sub 2^ as Better Thromboembolism DeterminantGarrett, Anna D
Further- more, female gender and vascular disease, differential factors be- tween CHA2DS2VASc and CHADS2 scores, are also related to increas- ing systemic inflammation.56-58) Therefore, patients with higher CHADS2 and CHA2DS2VASc scores may have a more severe inflam- mation, and the anti-...
The CHADS2 and CHA2DS2VASc scoring systems have been used for stroke risk stratification in AF patients. The recent study suggested that these scores can also be used to guide statin therapy for AF prevention. Patients with higher scores had a higher risk of developing AF and gained more ...
(0.651–0.683)forCHA2DS2-VASc(nosignificantdifference).Fornon-anticoagulationpatients,thepooledC-statistic(95%CI)was0.685(0.666–0.705)forCHADS2and0.675(0.656–0.694)forCHA2DS2-VASc(nosignificantdiffer-ence).Theaverageratioofendpointeventsinthelow-riskgroupofCHA2DS2-VAScwaslessthanCHADS2(0.41%vs.0.94...
a最新研究认为CHA2DS2-VASc评分较CHADS2评分更为完善,对NVAF患者卒中风险有更好的预测作用,但目前国内外有关其在NVAF缺血性脑卒中患者中的临床应用的资料较少。 The newest research thought the CHA2DS2-VASc grading compares the CHADS2 grading to be more perfect, has the better forecast function to the ...